Table 2 Vitiligo Area Scoring Index scores at baseline and week 12, n = 11
From: Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial
Area | Â | % area of vitiligo (SD) | extent of depigmentation (0,10,25,50,75,90,100) (SD) | VASI score (SD) |
|---|---|---|---|---|
hands (0-4%) | baseline | 1.08 (0.93) | 37.27 (35.73) | 0.51 (0.56) |
| Â | week 12 | 1.08 (0.93) | 35.91 (34.27) | 0.50 (0.57) |
| Â | change | 0.00 p = 0 | -1.36 p = 0.21 | -0.01 p = 0.21 |
upper extremities (0-18%) | baseline | 1.10 (1.69) | 34.55 (41.02) | 0.70 (1.38) |
| Â | week 12 | 1.10 (1.69) | 30.91 (35.48) | 0.63 (1.18) |
| Â | change | 0.00 p = 0 | -3.64 p = 0.20 | -0.07 p = 0.35 |
trunk (0-36%) | baseline | 2.87 (4.04) | 69.64 (32.58) | 1.66 (1.53) |
| Â | week 12 | 2.85 (4.04) | 58.64 (32.95) | 1.43 (1.57) |
| Â | change | -0.02 p = 0.36 | -11.00 p = 0.11 | -0.22 p = 0.10 |
lower extremities (0-36%) | baseline | 2.12 (2.12) | 57.73 (29.78) | 1.32 (1.57) |
| Â | week 12 | 2.12 (2.13) | 50.00 (26.36) | 1.13 (1.37) |
| Â | change | 0.00 p = 0.36 | -7.73 p = 0.08 | -0.20 p = 0.23 |
feet (0-6%) | baseline | 1.14 (1.41) | 50.00 (41.17) | 0.79 (1.26) |
| Â | week 12 | 1.12 (1.40) | 50.00 (41.17) | 0.78 (1.26) |
| Â | change | -0.02 p = 0.36 | 0.00 p = 0 | 0.00 p = 0.36 |
total VASI (0-100%) | baseline | Â | Â | 4.97 (4.74) |
| Â | week 12 | Â | Â | 4.47 (4.69) |
| Â | change | Â | Â | -0.51 p = 0.02 |